Actualités de India

Filtre
  • 11.10.2013 – 10:02

    Infosys Technologies Ltd.

    Infosys (NYSE: INFY) Announces Results for the Quarter Ended September 30, 2013

    Bangalore, India (ots/PRNewswire) - Q2 revenues grew by 15.0% year-on-year; 3.8% quarter-on-quarter (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) Financial Highlights Consolidated results under International Financial Reporting Standards (IFRS) for the quarter ended September 30, 2013 Business Highlights - Revenues were $2,066 million for the quarter ended ...

  • 03.10.2013 – 17:25

    Infosys Technologies Ltd.

    Infosys to Announce Second Quarter Results on October 11, 2013

    Bangalore, India And Plano, Texas (ots/PRNewswire) - Infosys Limited , a global leader in consulting, technology and outsourcing services, will announce results for its second quarter ended September 30, 2013 on Friday, October 11, 2013, Indian Standard Time (IST) (on the night of Thursday, October 10, 2013, US Eastern Time (ET)). The results will also be available on the Infosys website http://www.infosys.com. (Logo: ...

  • 12.07.2013 – 09:12

    INFOSYS

    Infosys (NYSE: INFY) Announces Results for the Quarter Ended June 30, 2013

    Bangalore, India (ots/PRNewswire) - Q1 revenues grew by 13.6% year-on-year; 2.7% quarter-on-quarter Financial Highlights Consolidated results under International Financial Reporting Standards (IFRS) for the quarter ended June 30, 2013 - Revenues were $1,991 million for the quarter ended June 30, 2013 QoQ growth was 2.7% YoY growth was 13.6% - Net profit was $ 418 ...

  • 05.07.2013 – 10:49

    INFOSYS

    Infosys to Announce First Quarter Results on July 12, 2013

    Bangalore, India And Fremont, California (ots/PRNewswire) - Infosys Limited , a world leader in consulting and information technology services, will announce results for its first quarter ended June 30, 2013 on Friday, July 12, 2013, Indian Standard Time (IST) (on the night of Thursday, July 11, 2013, US Eastern Time (ET)). The results will also be available on the Infosys website http://www.infosys.com. (Logo: ...

  • 12.04.2013 – 10:54

    INFOSYS

    Infosys (NYSE: INFY) Announces Results for the Quarter and Year ended March 31, 2013

    Bangalore, India (ots/PRNewswire) - Q4 revenues grew by 1.4% sequentially; FY13 revenues grew by 5.8% Financial Highlights Consolidated results under International Financial Reporting Standards (IFRS) for the quarter ended March 31, 2013 - Revenues were $1,938 million for the quarter ended March 31, 2013; QoQ growth was 1.4% YoY growth was 9.4% - Net profit was $444 ...

  • 19.03.2013 – 12:55

    UBM Live Routes Ltd

    Routes Asia Officially Handed Over to Kuching for 2014

    Mumbai, India (ots/PRNewswire) - After a successful Routes Asia in Mumbai which saw over 700 hundred delegates in attendance, more than ever before, GVK's Chhatrapati Shivaji International Airport (CSIA) have officially handed the event over to Kuching, Sarawak the host destination for Routes Asia 2014. Building on the success of this year's event the largest route development forum for the entire Asia region will take ...

  • 18.03.2013 – 18:47

    UBM Live Routes Ltd

    Routes Asia Awards 2013 Winners Announced

    Mumbai, India (ots/PRNewswire) - Changi Airport Group crowned overall winner at second regional heat of 2013 Earlier this evening during a lavish networking evening on the lawns of the Renaissance Mumbai Hotel, Changi Airport Group was announced as the winner of the Asia heat of this year's Routes Airport Marketing Awards. Over 700 aviation professionals were gathered to witness the presentation of the awards and to take ...

  • 22.02.2013 – 14:22

    Lupin Ltd

    Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL

    Mumbai, India And Baltimore (ots/PRNewswire) - Approval to add to growing SUPRAX(R) Franchise Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX(R) (Cefixime) for Oral Suspension, 500 mg/5mL from the United States Food and Drugs Administration (FDA). Lupin expects to commence ...

  • 14.02.2013 – 13:33

    INFOSYS

    Infosys Limited's American Depositary Shares Approved for Listing on NYSE Euronext Paris

    Bangalore, India (ots/PRNewswire) - Infosys, a global leader in consulting and technology, today announced that the French Autorite des marches financiers (AMF) has approved the Company's prospectus for admission of its American Depositary Shares for listing and trading on the Professional Segment of NYSE Euronext Paris, and has granted visa number 13-029, dated ...

  • 12.02.2013 – 09:00

    Verein Tibeter Jugend in Europa / The Tibetan Youth Association in Europe

    The Tibetan Youth Association in Europe Demands: Put Tibet on Google Maps

    Zurich/Dharamsala, India (ots) - On the occasion of the centennial of Tibet's proclamation of independence, the Tibetan Youth Association in Europe (TYAE) is approaching Google with an urgent demand: Tibetan places on Google Maps should be labeled in Tibetan script. To stop the disappearance of Tibetan cultural heritage, the TYAE is hereby launching the campaign forum ...

  • 11.01.2013 – 09:02

    INFOSYS

    Infosys Announces Results for the Quarter Ended December 31, 2012

    Bangalore, India (ots/PRNewswire) - Q3 Revenues Grow by 6.3% Quarter on Quarter Financial Highlights Consolidated results under International Financial Reporting Standards (IFRS) for the quarter ended December 31, 2012 - Revenues were $1,911 million for the quarter ended December 31, 2012; QoQ growth was 6.3% YoY growth was 5.8% - Revenues excluding Lodestone were $1,872 million; QoQ growth was 4.2% YoY growth was 3.7% - ...

  • 30.11.2012 – 16:18

    Infosys Technologies Ltd.

    Infosys Plans to List its ADS on the NYSE Euronext

    Bangalore, India (ots/PRNewswire) - Infosys, a global leader in consulting and technology, today announced that it will be transferring the listing of its American Depositary Shares (ADS) to the New York Stock Exchange (NYSE) from the NASDAQ Global Select Market (NASDAQ). The company is also seeking to list its ADS on the Paris and London exchanges of NYSE Euronext. Infosys ADS will begin trading on the NYSE Euronext ...

  • 23.11.2012 – 07:37

    Infosys Technologies Ltd.

    Infosys Science Foundation Announces Winners of the Infosys Prize 2012

    Bangalore, India (ots/PRNewswire) - - Honors ground-breaking research in science, mathematics and humanities The Infosys Science Foundation [http://www.infosys-science-foundation.com ] today announced the winners of the Infosys Prize 2012 for their outstanding research contributions across six categories: Engineering & Computer Science, Humanities, Life Sciences, ...

  • 22.10.2012 – 12:44

    Infosys Technologies Ltd.

    Infosys Completes Acquisition of Lodestone Holding AG

    Bangalore, India (ots/PRNewswire) - Agreement creates world-class team to accelerate transformation and innovation-led growth Infosys, a global leader in consulting and technology, today announced it has completed the acquisition of Lodestone Holding AG, a leading management consultancy based in Switzerland. The acquisition is in accordance with the terms set out in the agreement announced on September 10 ...

  • 12.10.2012 – 10:03

    Infosys Technologies Ltd.

    Infosys (NASDAQ: INFY) Announces Results for the Quarter Ended September 30, 2012

    Bangalore, India (ots/PRNewswire) - Q2 Revenues grew by 2.9% Year on Year Highlights Consolidated results under International Financial Reporting Standards (IFRS) for the quarter ended September 30, 2012 Revenues were $1,797 million for the quarter ended September 30, 2012; YoY growth was 2.9% Net income after tax was $431 million for the quarter ended September 30, ...

  • 10.09.2012 – 07:24

    Infosys Technologies Ltd.

    Infosys to Acquire Lodestone, a Leading Management Consultancy Firm

    Zurich And Bangalore, India (ots/PRNewswire) - ? - Strengthens Infosys management consulting capabilities globally - Expands presence in continental Europe adding more than 750 experienced consultants and 200 clients - Deepens expertise across Manufacturing, Automotive and Life Sciences industries - Infosys Consulting practice focusing on SAP programs to become a $1 ...

  • 17.08.2012 – 09:02

    UBM India Pvt. Ltd.

    SATTE 2013 Garners Interest

    Mumbai, India (ots/PRNewswire) - Prevailing economic conditions have compelled the global travel industry to look at new source markets and India stands in the top two As we gear up for SATTE 2013, there has been a keen interest in South Asia's leading travel mart. With India now being looked at more favourably as a very important market for global tourism products, SATTE is undoubtedly the ideal platform for newer destinations to tap into the Indian market. The current ...

  • 19.07.2012 – 12:48

    CPhI Conferences India

    Insights on Regulatory, QbD and Formulation of Nano Medicines at Nano Suspensions India 2012

    Hyderabad, India (ots/PRNewswire) - CPhI introduces Nano Suspensions India 2012 [http://ubmindia.co.in/cgi-bin18/DM/t/hzOj0dsj5Y0KYO0J7160EG ] which will be focusing on the most relevant and pressing issues around regulatory, QbD, solubility, stability and efficient scale-up of nano medicines. Taking place on 21-22 August 2012 at Fortune Select Manohar, Hyderabad, ...

  • 13.04.2012 – 10:36

    Infosys Technologies Ltd.

    Infosys (NASDAQ: INFY) Announces Results for the Quarter and Year Ended March 31, 2012

    Bangalore, India (ots/PRNewswire) - Q4 revenues declined by 1.9% sequentially; FY12 revenues grew by 15.8% Fiscal 2013 revenues expected to grow by 8.0% to 10.0% Highlights Consolidated results under International Financial Reporting Standards (IFRS) for the quarter ended March 31, 2012 - Revenues were $1,771 million for the quarter ended March 31, 2012; QoQ decline ...

  • 07.11.2011 – 10:00

    DNDi - Drugs for Neglected Diseases initiative

    Major Project Launched to Support India and Bangladesh's National Control Programmes in Implementing New Treatments to Boost Kala-Azar Elimination Strategies

    Geneva, Switzerland/New Delhi, India (ots) - A comprehensive four-year project including over 10,000 patients in clinical and pharmacovigilance studies for diagnosis and treatment of visceral leishmaniasis (VL, also known as kala-azar) in India and Bangladesh was launched by an international consortium formed last ...